Showing 7591-7600 of 10799 results for "".
- ZO Skin Health Opens in Pasadenahttps://practicaldermatology.com/news/20121203-zo_skin_health_opens_in_pasadena/2459666/ZO® Skin Health, described as a cutting-edge center that offers the latest in skin transformation and anti-aging technology and treats a wide range of skin conditions including acne, scars, large pores and skin imperfections, opened November
- CryoShape Uses Cold to Reduce Scarshttps://practicaldermatology.com/news/20121203-cryoshape_uses_cold_to_reduce_scars/2459667/CryoShape is a patented handheld device for treating keloid and hypertrophic scars. Physicians can destroy deep tissue using an extremely cold probe that is injected directly into the scar. Treating scars with cold freezes them from the inside,
- Tofacitinib Citrate Approved for Rheumatoid Arthritishttps://practicaldermatology.com/news/20121203-tofacitinib_citrate_approved_for_rheumatoid_arthritis/2459668/Pfizer Inc. received US FDA approval for XELJANZ (tofacitinib citrate) 5mg twice daily for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. XELJANZ
- Physician Income "Disappointing," But Up Slightlyhttps://practicaldermatology.com/news/20121121-physician_income_disappointing_but_up_slightly/2459674/Although most physicians report that their net income is "disappointing," American physicians saw a slight uptick in income in 2012 compared to 2011, a new report shows. Specialists continue to outpace primary care physicians; 40% of the latter make less than $150,000 per year,
- Sun Pharmaceutical to Buy DUSA Pharmaceuticalshttps://practicaldermatology.com/news/20121118-sun_pharmaceutical_to_buy_dusa_pharmaceuticals/2459678/Sun Pharmaceutical Industries Ltd. will buy DUSA Pharmaceuticals Inc. for about $215 million in cash, as the India-based company looks to make a foray into the lucrative market for dermatological treatments. The deal has been unanimously approved by the boards of both companies and DUSA's board has
- Allergan to Acquire SkinMedicahttps://practicaldermatology.com/news/20121116-allergan_to_acquire_skinmedica/2459680/Allergan, Inc. is set to acquire SkinMedica's topical aesthetics skin care business, in a deal estimated at approximately $350 million up-front. Allergan will also pay SkinMedica an additional $25 million contingent upon the acquired products achieving a specific level of net sales. The acquisition
- Cosmetic Surgery Forum Names Honoreeshttps://practicaldermatology.com/news/20121101-cosmetic_surgery_forum_names_honorees/2459685/Richard Fitzpatrick, MD and Diane Ranger, founder of Colorescience, will receive the “Innovators in Dermatology Award” at Cosmetic Surgery Forum 2012 in Las Vegas, November 29 through December 1. Jonah Schacknai, Founder and CEO of Medicis Pharmaceuticals, will receive the Lifetime Service Award. Re
- Asclera's "Stand and Deliver" to Recognize Inspirational Womenhttps://practicaldermatology.com/news/20121101-ascleras_stand_and_deliver_to_recognize_inspirational_women/2459686/Nominations are being accepted through December 31, 2012 for the Stand and Deliver program sponsored by Merz Aesthetics, exclusive distributor of Asclera® (polidocanol) injec
- Medical Entrepreneur Symposium Adds Breakout Sessionhttps://practicaldermatology.com/news/20121024-medical_entrepreneur_symposium_adds_breakout_session/2459693/The Medical Entrepreneur Symposium, a unique educational meeting for physicians, their office managers, and executives in healthcare, has added a breakout session for physician entrepreneurs wanting to take great business ideas or medical devices to market. Dr. Arlen Meyers will be the course direct
- STELARA Wins 2012 International Prix Galien Awardhttps://practicaldermatology.com/news/20121022-stelara_wins_2012_international_prix_galien_award/2459698/Janssen Biotech, Inc. announced that STELARA was named the 2012 International Prix Galien award winner in Lyon, France. The honor is acknowledgment of the technical, scientific, and clinical research skills necessary to develop innovative medicines and devices. The international Prix Galien Award is